NCT02983890View on ClinicalTrials.gov

Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 6, 2016

Primary Completion Date

April 5, 2017

Study Completion Date

October 1, 2017

Conditions
Healthy
Interventions
DRUG

Dicloxacillin

"Tablets containing dicloxacillin are taken 500mg 2x 3 times per day, for 10 days. Followed by test-day nr 1 at day 11.~Both arms receives both treatments, randomly assigned"

DRUG

Placebos

"No drug are taken for 10 days. Non-blinded. Followed by test-day nr 1 at day 11.~Both arms receives both treatments, randomly assigned"

Trial Locations (1)

5000

Klinisk Biokemisk Farmakologi syddansk universitet, Odense

All Listed Sponsors
lead

Per Damkier

OTHER

NCT02983890 - Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism. | Biotech Hunter | Biotech Hunter